Allan B. Haberman, Ph.D. is Principal of Haberman Associates in addition to Founder and Principal of the Biopharmaceutical Consortium.
Dr. Haberman’s consulting activities include work in:
- new product development and technology strategy in addition to;
- opportunity assessment;
- assessment of drug pipelines;
- due diligence on established and emerging biotechnology companies
He is also the author of numerous books and reports plus published articles on the pharmaceutical and biotechnology industry, R&D strategy, therapeutic area and pipeline strategy, and technology assessment. For more information, see our publications page.
Most noteworthy, Dr. Haberman also speaks at national and international conferences on the pharmaceutical and biotechnology industry and on drug discovery and development. For information on presentations offered by Haberman Associates, please see our Speaking and Seminars page.
Prior to forming Haberman Associates, Dr. Haberman was the Associate Director of the Biotechnology Engineering Center at Tufts University. He received his Ph.D. in biochemistry and molecular biology from Harvard University.